Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam
· Delayed Price · Currency is VND 61,000
-1,900 (-3.02%)
At close: Mar 9, 2026
HNX:DP3 Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 153,561 | 121,172 | 125,263 | 108,824 | 94,305 | Upgrade
|
| Depreciation & Amortization | 11,556 | 12,861 | 13,980 | - | - | Upgrade
|
| Other Amortization | 80 | 80 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -15,492 | -21,684 | - | - | Upgrade
|
| Other Operating Activities | 76,878 | -1,041 | 4,079 | -9,609 | -67,997 | Upgrade
|
| Change in Accounts Receivable | - | -24,076 | 13,163 | - | - | Upgrade
|
| Change in Inventory | - | 8,406 | 17,504 | - | - | Upgrade
|
| Change in Accounts Payable | - | -10,859 | -414.91 | - | - | Upgrade
|
| Change in Other Net Operating Assets | - | 866.97 | 1,211 | - | - | Upgrade
|
| Operating Cash Flow | 242,076 | 91,917 | 153,102 | 99,215 | 26,308 | Upgrade
|
| Operating Cash Flow Growth | 163.36% | -39.96% | 54.31% | 277.13% | -78.50% | Upgrade
|
| Capital Expenditures | - | -1,465 | -6,403 | -15,089 | -446.26 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 269.41 | 1,824 | - | - | Upgrade
|
| Other Investing Activities | 10,791 | 16,852 | 17,521 | 8,814 | 6,324 | Upgrade
|
| Investing Cash Flow | -132,210 | -11,330 | -102,680 | -54,654 | 25,878 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 15,414 | 10,210 | Upgrade
|
| Long-Term Debt Issued | - | 10,100 | 15,110 | - | - | Upgrade
|
| Total Debt Issued | - | 10,100 | 15,110 | 15,414 | 10,210 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -12,222 | -12,060 | Upgrade
|
| Long-Term Debt Repaid | -56,899 | -17,875 | -12,565 | -1,490 | - | Upgrade
|
| Total Debt Repaid | -56,899 | -17,875 | -12,565 | -13,712 | -12,060 | Upgrade
|
| Net Debt Issued (Repaid) | -56,899 | -7,775 | 2,545 | 1,702 | -1,850 | Upgrade
|
| Common Dividends Paid | -62,199 | -64,481 | -68,698 | -49,885 | -66,529 | Upgrade
|
| Financing Cash Flow | -119,098 | -72,256 | -66,153 | -48,183 | -68,379 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.18 | 0.27 | 0.72 | 25.84 | 2.48 | Upgrade
|
| Net Cash Flow | -9,231 | 8,331 | -15,731 | -3,596 | -16,191 | Upgrade
|
| Free Cash Flow | 242,076 | 90,452 | 146,699 | 84,126 | 25,862 | Upgrade
|
| Free Cash Flow Growth | 167.63% | -38.34% | 74.38% | 225.29% | -52.21% | Upgrade
|
| Free Cash Flow Margin | 55.27% | 21.67% | 35.80% | 17.34% | 6.79% | Upgrade
|
| Free Cash Flow Per Share | 11259.39 | 4207.10 | 6823.21 | 3717.11 | 1202.91 | Upgrade
|
| Cash Interest Paid | 673.58 | 188.5 | 1,567 | 2,868 | 1,207 | Upgrade
|
| Cash Income Tax Paid | 31,179 | 31,740 | 27,665 | 24,159 | 29,399 | Upgrade
|
| Levered Free Cash Flow | 122,345 | 77,061 | 127,650 | 60,230 | 55,727 | Upgrade
|
| Unlevered Free Cash Flow | 122,779 | 77,162 | 128,646 | 64,277 | 56,008 | Upgrade
|
| Change in Working Capital | - | -25,662 | 31,463 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.